Jon Blaskovich
Chief Tech/Sci/R&D Officer en BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. .
Perfil
El Sr. Jon Blaskovich es Director de Tecnología de la Información en Biohaven Pharmaceutical Holding Co. Ltd. Se licenció en el Rochester Institute of Technology.
Cargos activos de Jon Blaskovich
Empresas | Cargo | Inicio |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | - |
BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Jon Blaskovich.
Empresas | Cargo | Fin |
---|---|---|
Epsilon Data Management LLC
Epsilon Data Management LLC Advertising/Marketing ServicesCommercial Services Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX. | Chief Tech/Sci/R&D Officer | - |
Formación de Jon Blaskovich.
Rochester Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOHAVEN LTD. | Health Technology |
Empresas privadas | 2 |
---|---|
Epsilon Data Management LLC
Epsilon Data Management LLC Advertising/Marketing ServicesCommercial Services Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Jon Blaskovich